Wernert N - Search Results

1

Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course.

Perner S, Rupp NJ, Braun M, Rubin MA, Moch H, Dietel M, Wernert N, Jung K, Stephan C, Kristiansen G. Perner S, et al. Among authors: wernert n. Int J Cancer. 2013 Feb 15;132(4):807-12. doi: 10.1002/ijc.27733. Epub 2012 Aug 30. Int J Cancer. 2013. PMID: 22821757 Free article.

2

ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies.

Braun M, Goltz D, Adler D, Vogel W, Böhm D, Scheble V, Sotlar K, Fend F, Tan SH, Dobi A, Kristiansen G, Wernert N, Perner S. Braun M, et al. Among authors: wernert n. Prostate Cancer Prostatic Dis. 2012 Jun;15(2):165-9. doi: 10.1038/pcan.2011.67. Epub 2012 Jan 10. Prostate Cancer Prostatic Dis. 2012. PMID: 22231490

3

Rearrangement of the ETS genes ETV-1, ETV-4, ETV-5, and ELK-4 is a clonal event during prostate cancer progression.

Alder D, Braun M, Nikolov P, Boehm D, Scheble V, Menon R, Fend F, Kristiansen G, Perner S, Wernert N. Alder D, et al. Among authors: wernert n. Hum Pathol. 2012 Nov;43(11):1910-6. doi: 10.1016/j.humpath.2012.01.018. Epub 2012 May 7. Hum Pathol. 2012. PMID: 22569213

4

Improved method of detecting the ERG gene rearrangement in prostate cancer using combined dual-color chromogenic and silver in situ hybridization.

Braun M, Stomper J, Boehm D, Vogel W, Scheble VJ, Wernert N, Adler D, Fend F, Kristiansen G, Perner S. Braun M, et al. Among authors: wernert n. J Mol Diagn. 2012 Jul;14(4):322-7. doi: 10.1016/j.jmoldx.2012.01.017. Epub 2012 May 27. J Mol Diagn. 2012. PMID: 22642898 Free article.

5

ERG rearrangement in local recurrences compared to distant metastases of castration-resistant prostate cancer.

Scheble VJ, Scharf G, Braun M, Ruiz C, Stürm S, Petersen K, Beschorner R, Bachmann A, Zellweger T, Fend F, Kristiansen G, Bubendorf L, Wernert N, Adler D, Perner S. Scheble VJ, et al. Among authors: wernert n. Virchows Arch. 2012 Aug;461(2):157-62. doi: 10.1007/s00428-012-1270-7. Epub 2012 Jul 6. Virchows Arch. 2012. PMID: 22767266

6

ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer.

Adler D, Ochsenfahrt J, Fuchs K, Kristiansen G, Perner S, Wernert N. Adler D, et al. Among authors: wernert n. Int J Mol Med. 2012 Nov;30(5):1029-33. doi: 10.3892/ijmm.2012.1097. Epub 2012 Aug 20. Int J Mol Med. 2012. PMID: 22922762 Free PMC article.

7

Quantification of protein expression in cells and cellular subcompartments on immunohistochemical sections using a computer supported image analysis system.

Braun M, Kirsten R, Rupp NJ, Moch H, Fend F, Wernert N, Kristiansen G, Perner S. Braun M, et al. Among authors: wernert n. Histol Histopathol. 2013 May;28(5):605-10. doi: 10.14670/HH-28.605. Epub 2013 Jan 30. Histol Histopathol. 2013. PMID: 23361561

8

MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer.

Adler D, Menon R, Braun M, Offermann A, Queisser A, Boehm D, Vogel W, Rüenauver K, Ruiz C, Zellweger T, Svensson M, Andren O, Kristiansen G, Wernert N, Bubendorf L, Kirfel J, Biskup S, Perner S. Adler D, et al. Among authors: wernert n. Int J Cancer. 2014 Jul 1;135(1):19-26. doi: 10.1002/ijc.28647. Epub 2013 Dec 9. Int J Cancer. 2014. PMID: 24374838 Free article.

9

Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer.

Goltz D, Montani M, Braun M, Perner S, Wernert N, Jung K, Dietel M, Stephan C, Kristiansen G. Goltz D, et al. Among authors: wernert n. Pathology. 2015 Dec;47(7):629-36. doi: 10.1097/PAT.0000000000000320. Pathology. 2015. PMID: 26517642

10

The peripheral zone of the prostate is more prone to tumor development than the transitional zone: is the ETS family the key?

Adler D, Lindstrot A, Ellinger J, Rogenhofer S, Buettner R, Perner S, Wernert N. Adler D, et al. Among authors: wernert n. Mol Med Rep. 2012 Feb;5(2):313-6. doi: 10.3892/mmr.2011.647. Epub 2011 Oct 27. Mol Med Rep. 2012. PMID: 22038307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page